Meghan Hosely

Having a robust human research protection program (HRPP) in place is vital when maintaining compliance and keeping participants safe.

In a complex and competitive climate, we sought the understand existing perceptions surrounding clinical research trials.

Gain a comprehensive understanding of the various phases involved in clinical research, their objectives, and outcomes that ensure safe and effective clinical treatment.

Discover valuable insights and expert guidance on navigating FDA inspections in clinical research.

Data safety monitoring boards (DSMBs) ensure research participants are protected and results are valid. Learn about DSMB composition, concerns, charter, and challenges.

Key strategies for successful research study startup: site selection, documentation, and effective initiation.

Discover how CTMS streamlines patient recruitment & management for successful clinical trials.

FDA recently released new guidance, potentially impacting early-phase cell and gene therapy trials.

Sickle cell disease significantly impacts the African American population, a minority community historically underserved by clinical research.

Recent signals have indicated the FDA plans to provide greater support for cell and gene therapy research.

Until the 1980s, children were excluded from research studies. Now, FDA provides draft guidance on ethically including kids in trials.